HomeHealth articlespancreatic tumourWhat Are Somatostatinomas?

Somatostatinomas - Types, Causes, Symptoms, Diagnosis, and Treatment

Verified dataVerified data
0

4 min read

Share

Somatostatinomas are rare tumors that occur in the pancreas and small intestine. Read the below article to learn all about them.

Medically reviewed by

Dr. Kaushal Bhavsar

Published At September 28, 2022
Reviewed AtApril 17, 2023

Introduction:

Somatostatinomas are rare tumors occurring in the pancreas and the first part of the small intestine called the duodenum. Special cells called delta cells of the pancreas secrete the hormone somatostatin. Somatostatin prevents the release of hormones like insulin, glucagon, gastrin, and cholecystokinin, which manage blood sugars and movement of the gastrointestinal (GI) tract. Excess somatostatin causes an imbalance in these functions, causing symptoms. Though somatostatinomas are cancerous, early diagnosis and treatment with surgery can improve the chances of survival. They are very rare, affecting one in 40 million people. More than 50 percent of the tumors occur in the pancreas, while the rest occur in the duodenum. 75 percent of all cases are cancerous.

What Is the Other Name for Somatostatinoma?

Somatostatinomas are also referred to as functional pancreatic neuroendocrine tumors.

What Are the Types of Somatostatinomas?

Based on where the tumors are located, they are classified into two types, namely:

  1. Pancreatic somatostatinomas.

  2. Duodenal somatostatinomas.

1) Pancreatic Somatostatinomas:

Pancreatic somatostatinomas occur in the pancreas. Somatostatin is a hormone released by pancreatic cells that stops the functions of hormones like insulin and gastrin, when necessary. When excess somatostatin is produced, it leads to an imbalance in blood sugar levels and gastric mobility.

Sometimes, excess somatostatin causes a condition called somatostatinoma syndrome, which has symptoms like:

  • Diabetes (a metabolic disorder that causes high blood sugar levels).

  • Cholelithiasis, or gallstones, are cholesterol stones formed in the gallbladder, an organ in the abdomen.

  • Steatorrhea or oily stools.

2) Duodenal Somatostatinomas:

Duodenal somatostatinomas occur in the duodenum, the first part of the small intestine.

These types do not produce somatostatinoma syndrome, but the growing tumor causes symptoms. In most cases, the tumor spreads to the liver and lymph nodes, leading to obstruction of parts of the intestine and gallbladder. Obstruction causes symptoms like:

  • Swollen and painful abdomen.

  • Jaundice or yellowish discoloration of the skin and eyes.

  • Diarrhea.

  • Blood in stools.

What Are the Causes of Somatostatinomas?

The exact cause of somatostatinomas remains unknown. However, men and women between the ages of 40 to 60 are equally affected. Researchers suggest that about 37 percent of cases are hereditary, which often occur associated with other rare genetic syndromes like multiple endocrine neoplasias (MEN) type 1, neurofibromatosis, and Von-Hippel Lindau syndrome.

What Are the Risk Factors for Somatostatinomas?

The various risk factors for somatostatinomas include:

  • Age above 50 years.

  • Genetic abnormalities.

  • Smoking.

  • Alcohol consumption.

  • Pancreatitis (a long-standing inflammation of the pancreas).

  • Type 2 diabetes.

What Are the Signs and Symptoms of Somatostatinomas?

The symptoms of somatostatinomas usually are very mild in the beginning. As the tumor grows in size, they start to show up. Also, as the symptoms are similar to those of many possible medical conditions, it is important to make an appointment with a doctor who helps in making a correct diagnosis. It also ensures that the other possible causes are detected and treated appropriately.

The following signs and symptoms are noticed in people with somatostatinomas, which include:

  1. Abdominal pain (most common symptom).

  2. Diabetes occurs due to glucose intolerance (GI), a condition in which the cells do not take up glucose because of insulin deficiency.

  3. Loss of weight.

  4. Jaundice (a condition in which there is yellowing of the whites of the eye and skin.)

  5. Blockage of the bowels.

  6. Diarrhea.

  7. Steatorrhea or oily and foul-smelling stools.

  8. Stones in the gallbladder.

  9. Appetite loss.

  10. Nausea and vomiting.

Additional symptoms may be present if the tumor has spread to other structures or organs. Symptoms like abdominal pain or bowel blockage occur due to somatostatinomas in the small intestine.

How Are Somatostatinomas Diagnosed?

Doctors order the following tests that help diagnose somatostatinomas, which include blood tests and imaging tests.

Suspected patients are advised to take blood tests, which show extremely high levels of the hormone somatostatin, which is almost 1000 times or higher than normal.

Imaging tests help know the location of the tumor and also whether the tumors have spread to different body parts. Symptoms like abdominal pain, unexplained weight loss, or diarrhea indicate the need for imaging tests. The following tests are advised, which include:

  • CT (Computed Tomography) Scan: Cross-sectional images of the body parts are obtained based on several X-rays and computer processing. CT scan helps in detecting tumors in the pancreas and duodenum and also helps in assessing if the tumor has spread to nearby structures.

  • MRI (Magnetic Resonance Imaging) Scan: Uses magnetic fields and radio waves to provide precise details of the parts of the body. It is believed that an MRI scan is more useful when compared to a CT scan in detecting small tumors.

  • Somatostatin Receptor Scintigraphy: In this technique, the doctor injects a substance known as the somatostatin analog, which is mildly radioactive, into the body. This analog helps in detecting the tumors and also knowing the spread of the tumors.

  • Endoscopic Ultrasound: A tube with a camera at the end, guided by an ultrasound scan, is used to study the organs of the abdomen and is used to detect somatostatinomas.

  • Biopsy: Biopsy is a tissue sample collected from the suspected area and sent to the laboratory for analysis. Somatostatinomas are confirmed only after biopsy.

How Are Somatostatinomas Treated?

Management of somatostatinomas varies among different patients based on the symptoms. However, the primary form of treatment includes surgery to remove the tumors. In cases where the tumor has spread to different body parts, like the liver, it becomes difficult to treat the tumor with surgery alone. Apart from surgery, a technique called chemo-embolization or hepatic embolization is employed in which a chemical or blood clot is introduced into the artery of the liver, thereby preventing blood supply to the tumor, which makes the tumor cells die. Chemotherapy, a treatment that uses medicines to stop the growth of tumor cells, is also considered a treatment option. Supportive treatment for increased blood sugars and replacement of pancreatic enzymes helps in reducing the symptoms. Nutritional therapies to adjust the fluid, electrolyte, and nutritional deficiencies are also given.

What Are the Survival Rates for Somatostatinoma Patients?

The survival rate following removal of the tumor is more than ten years in 72 percent of the patients. Even for the tumors that have spread, the survival rates are higher when compared to other tumors of the hormone-producing cells.

Conclusion:

The long-term outlook of the condition depends on the early diagnosis and surgery to remove the tumor. Also, cases that have not spread to surrounding tissues have better chances of survival post-treatment. Regular checkups with doctors on a periodic basis are advised to assess the growth of tumors in other body parts. A balanced diet, regular physical activity, and a healthy lifestyle are recommended for patients to cope with the condition.

Frequently Asked Questions

1.

What Is a Pancreatic Somatostatinoma?

Somatostatin-stimulating tumors (SSTs) are a kind of NET (neuroendocrine tumor). They begin in the somatostatin-producing neuroendocrine cells. Most of our body's organs, including the pancreas and small bowel (duodenum), include neuroendocrine cells. The majority of somatostatinomas produce a lot of the hormone.

2.

What Happens in the Presence of Somatostatin-Producing Tumors?

Somatostatinoma patients are more likely to develop gallstones (because of decreased gallbladder contraction), insulin resistance, and diabetes mellitus. Additionally, individuals could develop loose, fatty stools as a result of decreased release of enzymes necessary for the digestion of fatty foods. also weight loss.

3.

Where Does Somatostatinoma Most Frequently Occur?

Somatostatinomas affect the pancreas in about 55 percent of cases, and the head of the pancreas accounts for 2/3 of all cases. The remainder develops either seldom in the jejunum or the duodenal ampulla and periampullary area. The liver, colon, and rectum are further unusual main sites.

4.

Why Does Diabetes Occur in Somatostatin-Producing Tumors or Somatostatinoma?

Somatostatin inhibits insulin secretion, which results in reduced glucose uptake and increased hepatic glucose synthesis. As a result, in around 95 percent of afflicted individuals, somatostatinoma is significantly linked to the onset of diabetes mellitus.

5.

Somatostatinoma: Is It Benign or Cancerous?

Somatostatinomas are uncommon gastrointestinal (GI) neuroendocrine tumors (NETs). Due to their quiet growth, they typically fail to demonstrate any symptoms until they are well advanced and manifest as a malignant condition.

6.

What Is the Ideal Therapy for Somatostatinomas?

Somatostatinomas are treated medically by reducing the amount of somatostatin produced, followed by surgical and or radiological procedures, peptide receptor irradiation, and targeted or cytotoxic medicines.

7.

How Are Somatostatinomas Detected?

Initial blood tests may reveal increased somatostatin hormone levels in people suspected of having somatostatinoma (normally values increase 1000-fold or greater). The direct identification of the tumor and the evaluation of metastases in different organs and lymph nodes are made possible by several imaging tests.

8.

What Issues Can Arise From Somatostatin-Producing Tumors?

Somatostatinoma syndrome commonly has complications such as fluid, electrolyte, and dietary abnormalities. Parenteral supplementation may be necessary for those with hormone-excess disorders in order to correct these deficiencies.

9.

What Constitutes a Somatostatin-Dependent Risk Factor?

Somatostatinomas are more likely to develop in people who smoke, drink alcohol, have pancreatitis, are diabetic, are older, and have certain genetic predispositions. To identify the tumors, a doctor may do blood tests or imaging examinations.

10.

What Constitutes the Somatostatinoma Triad?

Diabetic mellitus, cholelithiasis, and diarrhea or steatorrhea are the three symptoms that together make up the somatostatinoma syndrome, often known as the "inhibitory" syndrome.

11.

Why Is Octreotide Used to Treat Somatostatin-Producing Tumors or Somatostatinoma?

Hormones, including insulin, glucagon, and growth hormone, are frequently overproduced as a result of somatostatinomas, which can result in a variety of symptoms and consequences. Octreotide (somatostatin analog) binds to somatostatin receptors on the tumor cells, which inhibits the overproduction of these hormones. This lessens hormone secretion, which aids in symptom relief.

12.

What Is the Prognosis for Somatostatin-Producing Tumors?

Pancreatic somatostatin-producing tumors have a 10-year survival rate of around 72 percent. Somatostatinoma survival rates are greater than those of other neuroendocrine tumors even after they have spread. Thus, the prognosis is better than that of other neuroendocrine tumors.

13.

Is Hypoglycemia a Possible Result of Somatostatinoma?

Hypoglycemia may result from somatostatinoma. Somatostatin is a hormone that blocks the release of several hormones, including insulin and glucagon, and somatostatinomas are uncommon neuroendocrine tumors that generate excessive levels of this hormone. Blood sugar levels are brought down by insulin, whereas they are raised by glucagon. A somatostatinoma's overproduction of the hormone can inhibit the release of insulin and glucagon, which can cause hypoglycemia (low blood sugar).
Dr. Kaushal Bhavsar
Dr. Kaushal Bhavsar

Pulmonology (Asthma Doctors)

Tags:

somatostatinomapancreatic tumour
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

pancreatic tumour

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy